|Day Low/High||0.94 / 1.00|
|52 Wk Low/High||1.00 / 7.85|
The Collaboration will be led by Renowned Cell and Gene Therapy Experts Dr. John DiPersio and Dr. Mark Schroeder with Advisory support to Cellect by Prof. Negrin of Stanford and Dr. Cutler of Harvard Medical School
Supports Collaborations with Cell and Gene Therapy Companies
Recent FDA Hiring Decision Highlights Growing Importance of Cell and Gene Therapy Companies
The Korea-Israel Industrial R&D Foundation (KORIL-RDF) approves grant for the collaboration between Cellect and Cell2in, providing financing for the joint project
TEL AVIV, Israel, Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd.
Following US, EU, Russia and South Korean approval, Cellect Technology Patent has now also been approved in Japan and Australia
TEL AVIV, Israel, Nov. 1, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd.
Utilizing first in kind (patent pending) technology of FasL-magnetic beads to significantly improve the stem cells selection process
Study shows significant improvement in orthopedic healing process
- One-month assessment of half of the planned patients in the ApoGraft™ study show complete engraftment and zero related adverse events - First cohort of patients completed the full study showing safety and tolerability (zero Related Adverse Events...
Cellect Biomd was up after securing orphan drug status for its transplant anti-rejection drug.
Company's Securities to Continue Trading Only on NASDAQ Stock Exchange in US
Method of treatment patent provides important protection in type I diabetes, inflammatory bowel disease, graft versus host disease and transplant rejection
Companies will test lowering transplant rejection symptoms using Cellect's ApoGraft method for stem cells selection
Raised Gross Proceeds of $8.4 Million through Pricing of July U.S. Initial Public Offering
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.